Last $0.0030 USD
Change Today 0.00 / 0.00%
Volume 4.8K
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Francis E. O'Donnell Jr., M.D.

AgeTotal Calculated CompensationThis person is connected to 25 board members in 5 different organizations across 9 different industries.

See Board Relationships


Dr. Francis E. O'Donnell, Jr., also known as Frank, M.D., serves as the Chief Executive Officer, Managing Director, and Chairman of The Hopkins Capital Group. Dr. O'Donnell founded The Hopkins Capital Group in 1999. Dr. O'Donnell has been the Chief Executive Officer of Accentia Specialty Pharmaceuticals since September 2003 and serves as its Chairman. Dr. O'Donnell served as the Chief Executive Officer of BioDelivery Sciences International Inc. until March 7, 2013. He ...

Read Full Background

Corporate Headquarters*

324 South Hyde Park Avenue
Tampa, Florida 33606

United States

Phone: 813-864-2554
Fax: 813-258-6912

Board Members Memberships*

Executive Chairman
Chief Executive Officer, Founder, Managing Director, and Chairman
Former Director
Co-Founder and Chairman of the Board
Former Director
Former Director
Executive Chairman and Member of Executive Subcommittee
Executive Chairman
Former Executive Chairman, Non-Executive Chairman of Accentia Biopharmaceuticals Inc, Non-Executive Chairman of Accentia Inc., Chief Executive Officer of Accentia Inc., Chief Executive Officer of BioDelivery Science International Inc. and President of BioDelivery Science International Inc.


Unknown/Other Education 1975
Johns Hopkins School of Medicine

Other Affiliations*

Annual Compensation*

Total Annual Compensation$368,736

Stock Options*

Restricted Stock Awards$6,770
All Other Compensation$22,859

Total Compensation*

Total Annual Cash Compensation$783,190
Total Short Term Compensation$368,736
Other Long Term Compensation$29,629
Total Calculated Compensation$796,730
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABPI:US $0.00 USD 0.00


Michael S. Anderson Chief Executive Officer and Director
Flamel Technologies SA
Ronald W. Barrett Ph.D.Co-Founder, Chief Executive Officer and Director
Xenoport, Inc.
Peter William Grant Chief Executive Officer and Executive Director
Skyepharma PLC
567.0K GBP
Horst G. Zerbe Ph.D.Founder, Chairman of the Board, Chief Executive Officer and President
IntelGenx Technologies Corp.
Mark W. Schwartz Ph.D.Chief Executive Officer and President
Galena Biopharma, Inc.
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACCENTIA BIOPHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at